Here’s how experts said they would respond to injuries like Trump’s — and their thoughts on the lingering questions that have ...

Elevance said the amount of care its Medicaid members are getting is outpacing what states are paying the insurer to cover ...

Gilead Sciences’ chief medical officer will leave the company early next year as the drugmaker struggles to find new areas of ...

With resignations of top leaders, Cassava Sciences exposes a dark, ugly corner of the Alzheimer’s disease world, ...

Roche reported positive early data from an obesity drug candidate, bolstering the case it could become a player in the ...

Shares of Alnylam have been riding high since the biotech last month reported positive results from its pivotal HELIOS-B ...

It makes no sense that OB-GYN physicians should have to travel to Texas, a state with restrictive abortion laws, to take an ...

A clutch of headlines last week suggested the U.S. Senate had achieved a breakthrough in the battle to prevent pharmaceutical ...

Faced with widespread skepticism about the value of digital therapies, Swing Therapeutics in early 2022 set out to make the ...

Federal guidance restricting hospital websites’ use of third-party trackers along with the proliferation of ...

LONDON — Roche on Wednesday reported positive early data from another of the obesity drug candidates that it picked up ...

For scientists and medical professionals well versed in the safety and effectiveness of vaccines, it is often too easy to ...